NEWS
BioSpace I Life Sciences Industry Emphasizes Growth, Purpose in Fight for Talent

Two years ago, almost without warning, a global pandemic shook the world, and in an instant, made its citizens reconsider and reassess what is most important to us. Fear and forced isolation put family, friends and work-life balance at the top of this reassessment, and corporations now have some reevaluating of their own to do […]

BioSpace I Working Moms: Redefining Success & Finding Balance in the Life Sciences

With one in three employed women in the U.S. also raising children at home, and the majority of U.S. moms working at least part-time, moms are seriously putting in work. In 2021 the US Department of Labor found that between 62-72% of mothers in married-couple families are employed depending on the age of their children, while the proportion rises […]

BioSpace I Intercept, Annovis and Biohaven Advance Late Phase Trials

Several biopharma companies reported late-stage Phase III clinical trial success Thursday. Here’s a look. Positive Pivotal NASH Data Sets Intercept Up for NDA Resubmission Intercept Pharmaceuticals reported positive topline results from a new interim analysis of its ongoing pivotal Phase III REGENERATE trial. The study is evaluating obeticholic acid (OCA) in liver fibrosis (scarring) due to nonalcoholic […]